We used ROC plots to evaluate the clinical performance of the Guthrie, Wallac, and Isolab assays for newborn phenylketonuria (PKU) screening and assessed the screening discriminatory power of these three assays by the area under the ROC plot, Youden's J index, and the likelihood ratio. The use of these plots not only allows us to pinpoint the exact cutoff value in screening, but also provides a direct comparison of these three different assays in clinical outcome performance. The optimum cutoff for the newborn PKU screening is a blood phenylalanine concentration of 0.30, 0.27, and 0.18 mmol/L for the Guthrie, Wallac, and Isolab assays, respectively. We conclude that the Wallac and Isolab kits, like the Guthrie assay, are suitable for newborn PKU screening.
Newborn screening of phenylketonuria (PKU) 1 with a bacterial inhibition assay (BIA) on a filter-paper blood spot was established in Ontario in 1965. The BIA was developed by Guthrie and Susi [1] and is still used worldwide. The assay uses media formulated to grow Bacillus subtilis in an amount that is proportional to the concentration of phenylalanine in the blood spot. Recent development of quantitative determination of phenylalanine with the Wallac Quantase phenylalanine screening assay kit [2, 3] and the Isolab phenylalanine test kit has provided other methods for newborn PKU screening. The Wallac Quantase kit uses phenylalanine dehydrogenase to catalyze the NAD ϩ -dependent oxidative deamination of phenylalanine, and the NADH product is measured colorimetrically. The Isolab phenylalanine test kit is a modification of a fluorometric procedure involving a ninhydrin reaction, as published by McCaman and Robins [4] . This procedure is based on the enhancement of the fluorescence of a phenylalanine-ninhydrin reaction product by a dipeptide and the copper reagent in the succinate buffer solution. The method measures phenylalanine quantitatively in the presence of the other amino acids. Both the Wallac and Isolab kits offer the potential of an automated system. We evaluated the clinical performance of these three different assay procedures for newborn PKU screening with ROC plots. The ROC plot has become popular in recent years for evaluating the discriminatory power of a test [5] [6] [7] [8] [9] . The ROC plot displays graphically the relationship between the true-positive rate (TPR ϭ sensitivity) and the false-positive rate (FPR ϭ 1 Ϫ specificity) over all possible decision values. The decision value is the variable test value that is used to distinguish apparently healthy patients from diseased patients. We assessed the screening accuracy of these three assay systems by the area under the ROC plot [5] , Youden's J index [10] , and the likelihood ratio (LR) [11] .
Materials and Methods materials
The Wallac Quantase phenylalanine kits, a DELFIA plate punch (Model 1296-031D double-punch), a Multiscan microtiter plate reader with filters of 570 and 690 nm, and Multicalc Data Management Software were obtained from Wallac Canada. Millipore multiscreen special microfiltration plates were obtained from Millipore. 
methods
Wallac Quantase phenylalanine kit. The principle of this test kit is a quantitative determination of phenylalanine in a blood spot based on the use of phenylalanine dehydrogenase enzyme and its colorimetric measurement. The assay procedures were performed following the insert protocol of the company's kit. Two 3.2-mm dried blood spots punched from calibrators, controls, and patient specimens were extracted with 60 L of trichloroacetic acid (30 g/L) in a well of the Millipore microfilter plate. The plate was shaken for 30 min, and the extracts were transferred to a microtiter plate by a multiscreen Vacuum Manifold. The enzyme/coenzyme reagent was then added to each well. After a 30-min shaking incubation, 100 L of color reagent was added. The absorbance was read bichromatically at 570/690 nm, at the end of color development for 2-5 min. A complete assay run of three microplates takes about 2.7 h.
Isolab phenylalanine kit. The principle of this test kit is based on a modification of the fluorometric procedure published by McCaman and Robins [4] , with enhancement of the fluorescence of a phenylalanine-ninhydrin product by the l-leucyl-l-alanine dipeptide. In the assay procedure a 3.2-mm dried blood spot was punched into a microtitration well, 15 L of extraction solution was added to each well by the automated Isolab Sampler Processor, and the sample was incubated at 37°C for 30 min. Distilled-deionized water (40 L) was added and mixed, and 25 L of the contents was transferred to the corresponding plate by a Sampler Processor. The microplate was incubated for 2 h at 37°C after addition of 50 L of the PKU reagent. At the end of a 2-h incubation, 200 L of copper reagent was added and allowed to react for 45 min at room temperature before the microplate was read with an Isolab Fluorescent Plate Reader. A complete assay of three microplates takes about 4.5 h. ROC plot. The area under the ROC curve was estimated from the Metz program. 2 The LR is defined as the probability (P) of obtaining a positive test result in a patient with disease divided by the probability of obtaining a positive test in a patient without the disease [LR ϭ P/(1 Ϫ P) or P ϭ LR/(LR ϩ 1)]. A good LR is usually Ͼ2, which corresponds to the probability of having the disease being Ͼ66.7%. The LR [11] corresponds to the slope or tangent of a single selected decision value on the ROC plot and is simply calculated from the ratio of the TPR to the FPR, i.e., LR ϭ ⌬TPR/⌬FPR. Youden's J index [10] is a simple approach of minimizing error, equivalent to maximizing the sum of the sensitivity and specificity; it is calculated as J ϭ specificity ϩ sensitivity Ϫ 1, i.e., TPR Ϫ FPR. The index ranges from 0 for a worthless test to 1 for the perfect test.
Results
The TPR and FPR (%) for various blood phenylalanine concentrations of the Guthrie, Wallac, and Isolab assays are listed in Table 1 . The ROC areas of these three assays are 0.9982, 0.9972, and 0.9968, respectively. The same total number of 1076 apparently healthy patients and 21 diseased patients used in all three assays are also indicated in Table 1 . The ROC plots of TPR vs FPR for the assays are shown in Fig. 1 . An expanded scale of Fig. 1 with the FPR to 2.5% is shown in Fig. 1A .
Youden's J index plot for the three assays is shown in Fig. 2 . Youden's J index plot is to obtain the maximum index at the selected decision values. The best index is 98.6%, 98.7%, and 98.5% at the blood phenylalanine concentrations of 0.30, 0.27, and 0.18 mmol/L for the Guthrie, Wallac, and Isolab assays, respectively.
The LR plot of various phenylalanine concentrations of all three assays is shown in Fig. 3 . The LR of these three assays shows the identical optimum cutoff value of the blood phenylalanine concentrations as indicated in Youden's J index at 0.30, 0.27, and 0.18 mmol/L. At these optimum cutoff values, the LR is 10, 26, and 38 for the Guthrie, Wallac, and Isolab assays, respectively. It indicates the probability of having PKU is 90.9%, 96.3%, and 97.4% at the above-mentioned optimum cutoff values for the three assays.
Discussion
The ROC plot is a convenient way of expressing how well a test performs clinically. In newborn screening the ROC plot is particularly useful in evaluating the discriminatory ability of a test in displaying the error rates for selecting various cutoff points. For newborn screening, it is generally preferred to have a higher sensitivity test at the cost of many false-positives (low specificity), which could then be eliminated by an additional test as pointed out by Galen and Gambino [12] . Applying this principle to the ROC plot, we obtained a sensitivity (TPR) of 100% for all three assays at cutoff points of phenylalanine concentrations of 0.30, 0.27, and 0.18 mmol/L (Table 1) for the Guthrie, Wallac, and Isolab assays, respectively. At these cutoff points with 100% for TPR, the FPR for the Guthrie, Wallac, and Isolab assays are very close at 1.4%, 1.3%, and 1.5%, respectively. Therefore, all three assays may have similar performances for PKU screening. We had included 15 false-positive cases in the 1076 apparently healthy sample group for this evaluation. The actual FPR in the routine newborn screening population is much lower than that. The FPR for the Guthrie BIA is 0.07%, or ϳ100 cases per year in our routine PKU Screening Program of 150 000 newborns per year.
Some conditions exist such that a test with a high specificity is required at the expense of TPR when the disease is serious but is not treatable, and the FPRs have tremendous financial and psychological consequences for the patient, e.g., advanced carcinoma.
One indicator that quantifies the diagnostic accuracy of a laboratory test is the area under the ROC plot. The area under the ROC plot would be 1 for a perfect screening test. The ROC plot (Fig. 1 ) and its area (Table 1) show that the Guthrie test has a slightly higher value (0.9982) than the Wallac and Isolab kits, but the difference in area is not statistically significant (P ϭ 0.16). This is probably the main reason that the Guthrie BIA test is still the most commonly used screening procedure for detecting PKU in newborns throughout the world, despite the fact it is a semiquantitative method. The areas under the ROC plot of both the Wallac and the Isolab kits are close to each other, with values of 0.9972 and 0.9968, respectively. Both the Wallac and Isolab kits, however, have an advantage of easy automation over the Guthrie test. The area under the ROC plot provides only an overall index of test accuracy, not a measure of test performance at the selected decision values on the ROC plot. The ROC-related decision value plots, Youden's J index and LR (Figs. 2 and 3) , are useful for selecting the optimum decision value. Like the area under the ROC plot, Youden's J index and the LR combine sensitivity and specificity into a single factor and are extremely useful for assessing test performance. Unlike the above-mentioned approach of Galen and Gambino [12] in newborn screening, which gives overwhelming weight to TPR at the expense of FPR, Youden's approach and LR give equal weight to TPR and FPR. Comparing Youden's J index in Fig. 2 and LRs in Fig. 3 , we reconfirmed that the optimum screening cutoff point of the blood phenylalanine concentrations is identical to the one mentioned above (Table 1) : 0.30, 0.27, and 0.18 mmol/L for the Guthrie, Wallac, and Isolab assays, respectively. These different cutoff points may be a result of the different procedures used in preparation of the phenylalanine calibrators [13] .
The optimum screening cutoff point of 0.30 mmol/L of the Guthrie test is slightly higher than the normal value of 0.24 mmol/L used in our routine PKU screening. We use the lower than optimum value in the screening to ensure 100% sensitivity as discussed before. This should not affect the result of the comparison because the same specimens were applied to all three assays studied.
In conclusion, a ROC plot is particularly useful when comparing two or more testing kits. A test with a curve A is an expanded ROC plot of the inset with a FPR to 2.5%; छ, Guthrie; X, Wallac; F, Isolab. that lies statistically significantly above the curve of another will be clearly better. The results of this study suggest that both the Wallac and Isolab kits are suitable for PKU screening. The addition of the Wallac and the Isolab kits for PKU screening enable the laboratory to have a choice of screening assays, depending on the environment, manpower, and the requirement of automation. From the ROC plot, Youden's J index, and the LR studies, the optimum decision value of phenylalanine concentration on newborn PKU screening can be assessed easily.
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